Irinotecan

BCL2 apoptosis regulator ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34365218 Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. 2021 Nov 1
2 29541236 Differential sensitization of two human colon cancer cell lines to the antitumor effects of irinotecan combined with 5-aza-2'-deoxycytidine. 2018 Apr 10
3 24824514 The expression of genes involved in hepatocellular carcinoma chemoresistance is affected by mitochondrial genome depletion. 2014 Jun 2 1
4 22966396 Methylated BNIP3 gene in colorectal cancer prognosis. 2010 Sep 1
5 19440006 Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12. 2009 1
6 19673886 Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts. 2009 Nov 1
7 17367069 Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas. 2007 Mar 1
8 17487378 The interactive transcript abundance index [c-myc*p73alpha]/[p21*Bcl-2] correlates with baseline level of apoptosis and response to CPT-11 in human bronchogenic carcinoma cell lines. 2007 Jun 2
9 12712458 Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma. 2003 May 1 2
10 12907654 Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. 2003 Aug 1 1
11 11177741 Determinants of prognosis and response to therapy in colorectal cancer. 2001 Mar 1
12 9619871 4-Piperidinopiperidine-resistant lymphoma cells were resistant to dexamethasone- and A23187-induced apoptosis. 1998 May 15 1
13 9030234 [Apoptosis and chemosensitivity]. 1997 Jan 1
14 8476431 Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. 1993 Apr 15 1